Gabriele Roccuzzo

29PUBLICATIONS

64CO-AUTHORS

Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursMajor global burdens of diseaseAllergy

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (29)

Sort by Publication Date:

|Jun 26, 2026

Neoadjuvant Therapy and the Evolving Management of Resectable Advanced Melanoma.

|Jun 26, 2026

Adjuvant Approaches in Fully Resected Stage III and IV Cutaneous Melanoma: Where Are We Now?

|Jun 12, 2026

Adjuvant Therapy for High-Risk Stage II Cutaneous Melanoma: Insights and Future Directions.

|May 27, 2026

New Perspectives and Open Issues in the Adjuvant and Neoadjuvant Treatment of Melanoma.

|May 25, 2026

Utility of combined CD39/CD73/CD38 expression for the detection of malignant T cells in Sézary syndrome.

|Mar 17, 2026

Long-Term Outcomes of Secukinumab in Moderate-to-Severe Hidradenitis Suppurativa: A Multicentre Cohort Study.

Gianluca Avallone, Gabriele Roccuzzo, Luca Valtellini

Pageof 5

Frequent Collaborators

15 joint publications

Simone Ribero

10 joint publications

Pietro Quaglino

Paolo Fava

Gianluca Avallone

Alessandro Minisini

Andrea Spagnoletti

Michele Del Vecchio

Jacopo Pigozzo

Luca Mastorino

Francesco Cavallo

Frequent Collaborators

15 joint publications

Simone Ribero

10 joint publications

Pietro Quaglino

9 joint publications

Paolo Fava

5 joint publications

Gianluca Avallone